THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Oct. 12, 2004--Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, today announced that it plans to report its third quarter financial results on Wednesday, October 20, 2004 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. Pacific Standard Time.
Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call, including the question and answer session, is expected to last approximately one hour.
This event can be accessed by going to Amgen's Web site, www.amgen.com, and clicking on Investors. A link to the webcast is under the Events header. The event will be archived and available for replay for 72 hours after the event.
Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
Christine Cassiano, 805-447-4587 (media)
Laura Biswas, 805-447-1060 (investors)
SOURCE: Amgen Inc.